Recent Advances with Liposomes as Drug Carriers - Advanced Biomaterials and Biodevices - page 101

References
1. Bangham, A., M. Standish, and J. Watkins, Dif usion of univalent ions across
the lamellae of swollen phospholipids. Journal of Molecular Biology , 1965.
13(1): p. 238-IN27.
2. Gregoriadis, G. and B. Ryman, Liposomes as carriers of enzymes or drugs:
a new approach to the treatment of storage diseases. Biochemical Journal ,
1971. 124(5): p. 58P.
3. Zalba, S. and M.J. Garrido, Liposomes, a promising strategy for clinical
application of platinum derivatives. Expert Opin Drug Deliv , 2013. 10(6): p.
829-44.
4. Gregoriadis, G., Liposome Technology. Vol. I. 1993: CRC Press.
5. Banerjee, R., Liposomes: applications in medicine. Journal of Biomaterials
Applications , 2001. 16(1): p. 3-21.
6. Torchilin, V.P., Recent advances with liposomes as pharmaceutical carriers.
Nature Reviews Drug Discovery , 2005. 4(2): p. 145-160.
7. Sawant, R.R. and V.P. Torchilin, Challenges in development of targeted lipo-
somal therapeutics. AAPS J , 2012. 14(2): p. 303-315.
8. Maeda, H., et al. , Tumor vascular permeability and the EPR ef ect in macro-
molecular therapeutics: a review. Journal of Controlled Release , 2000. 65(1):
p. 271-284.
9. Hu, D., et al. , Pharmacokinetic proi le of liposome bupivacaine injection fol-
lowing a single administration at the surgical site. Clin Drug Investig , 2013.
33(2): p. 109-15.
10. Ismail, M.F., A.N. Elmeshad, and N.A. Salem, Potential therapeutic ef ect of
nanobased formulation of rivastigmine on rat model of Alzheimer's disease.
Int J Nanomedicine , 2013. 8: p. 393-406.
11. Kaszas, N., et al. , Ciprol oxacin encapsulation into giant unilamellar vesicles:
membrane binding and release. J Pharm Sci , 2013. 102(2): p. 694-705.
12. Liu, X., et al. , Clarithromycin-loaded liposomes of ering high drug loading
and less irritation. Int J Pharm , 2013. 443(1-2): p. 318-27.
13. Kim, B., et al. , Antitumor ef ect of a newly synthesized celecoxib derivative
encapsulated in liposome. Journal of Pharmaceutical Investigation , 2013.
43(2): p. 101-106.
14. Lalanne, M., et al. , Liposomal formulation of a glycerolipidic prodrug for
lymphatic delivery of didanosine via oral route. Int J Pharm , 2007. 344(1-2):
p. 62-70.
15. Wagner, E.J., L. Krugner-Higby, and T.D. Heath, Liposome dependent deliv-
ery of S-adenosyl methionine to cells by liposomes: a potential treatment for
liver disease. J Pharm Sci , 2009. 98(2): p. 573-82.
16. Bornmann, C., et al. , A new liposomal formulation of Gemcitabine is active
in an orthotopic mouse model of pancreatic cancer accessible to biolumines-
cence imaging. Cancer Chemother Pharmacol , 2008. 61(3): p. 395-405.